{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:54:33Z","timestamp":1771037673723,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273228"],"award-info":[{"award-number":["82273228"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["21ZR1461400"],"award-info":[{"award-number":["21ZR1461400"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s43032-024-01456-4","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T19:02:22Z","timestamp":1706036542000},"page":"1868-1880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hematological and Neurological Expressed 1 Promotes Tumor Progression Through mTOR Signaling in Ovarian Cancer"],"prefix":"10.1007","volume":"31","author":[{"given":"Pin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Heng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Na","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Zhi","family":"Gai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0447-8138","authenticated-orcid":false,"given":"Hui-Zhen","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"issue":"4","key":"1456_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3322\/caac.21559","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69(4):280\u2013304.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"1456_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/jnci\/djy071","volume":"111","author":"LC Peres","year":"2019","unstructured":"Peres LC, et al. Invasive epithelial ovarian cancer survival by histotype and disease stage. J Natl Cancer Inst. 2019;111(1):60\u20138.","journal-title":"J Natl Cancer Inst."},{"issue":"1","key":"1456_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin."},{"issue":"4","key":"1456_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284\u201396.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"1456_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199601043340101","volume":"334","author":"WP McGuire","year":"1996","unstructured":"McGuire WP, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med. 1996;334(1):1\u20136.","journal-title":"N Engl J Med."},{"issue":"9","key":"1456_CR6","doi-asserted-by":"publisher","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","volume":"20","author":"DK Armstrong","year":"2022","unstructured":"Armstrong DK, et al. NCCN guidelines\u00ae insights: ovarian cancer, version 3. 2022. J Natl Compr Cancer Netw: JNCCN. 2022;20(9):972\u201380.","journal-title":"J Natl Compr Cancer Netw: JNCCN."},{"key":"1456_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.gene.2004.02.025","volume":"331","author":"G Zhou","year":"2004","unstructured":"Zhou G, et al. Cloning, expression and subcellular localization of HN1 and HN1L genes, as well as characterization of their orthologs, defining an evolutionarily conserved gene family. Gene. 2004;331:115\u201323.","journal-title":"Gene."},{"issue":"9","key":"1456_CR8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s003359900540","volume":"8","author":"W Tang","year":"1997","unstructured":"Tang W, et al. Murine Hn1 on chromosome 11 is expressed in hemopoietic and brain tissues. Mamm Genome. 1997;8(9):695\u20136.","journal-title":"Mamm Genome."},{"issue":"3","key":"1456_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/cbin.11957","volume":"47","author":"J Feng","year":"2023","unstructured":"Feng J, et al. Hematological and neurological expressed 1 (HN1) activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of c-Myc in hepatocellular carcinoma. Cell Biol Int. 2023;47(3):560\u201372.","journal-title":"Cell Biol Int."},{"issue":"20","key":"1456_CR10","doi-asserted-by":"publisher","first-page":"6400","DOI":"10.1111\/febs.16531","volume":"289","author":"R Wang","year":"2022","unstructured":"Wang R, et al. The HN1\/HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin. FEBS J. 2022;289(20):6400\u201319.","journal-title":"FEBS J."},{"key":"1456_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2020.12.026","volume":"501","author":"Z Pan","year":"2021","unstructured":"Pan Z, et al. HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1. Cancer Lett. 2021;501:31\u201342.","journal-title":"Cancer Lett."},{"key":"1456_CR12","doi-asserted-by":"publisher","unstructured":"Wang F, Wang L, Gan S, et al. SERBP1 promotes stress granule clearance by regulating 26S proteasome activity and G3BP1 ubiquitination and protects male germ cells from thermostimuli damage. Research (Wash D C). 2023;6:0091.\u00a0https:\/\/doi.org\/10.34133\/research.0091","DOI":"10.34133\/research.0091"},{"key":"1456_CR13","doi-asserted-by":"publisher","unstructured":"Wang F, Ye Y, Zhang Z, et al. PDGFR in PDGF-BB\/PDGFR signaling pathway does orchestrates osteogenesis in a temporal manner. Research (Wash D C). 2023;6:0086.\u00a0https:\/\/doi.org\/10.34133\/research.0086","DOI":"10.34133\/research.0086"},{"key":"1456_CR14","doi-asserted-by":"publisher","unstructured":"Huang S. mTOR signaling in metabolism and cancer. Cells. 2020;9(10):2278.\u00a0https:\/\/doi.org\/10.3390\/cells9102278","DOI":"10.3390\/cells9102278"},{"issue":"6","key":"1456_CR15","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960\u201376.","journal-title":"Cell."},{"issue":"11","key":"1456_CR16","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1101\/gad.13.11.1422","volume":"13","author":"AC Gingras","year":"1999","unstructured":"Gingras AC, et al. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 1999;13(11):1422\u201337.","journal-title":"Genes Dev."},{"issue":"18","key":"1456_CR17","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1101\/gad.351605","volume":"19","author":"I Ruvinsky","year":"2005","unstructured":"Ruvinsky I, et al. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev. 2005;19(18):2199\u2013211.","journal-title":"Genes Dev."},{"issue":"17","key":"1456_CR18","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","volume":"21","author":"RF Ozols","year":"2003","unstructured":"Ozols RF, et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol. 2003;21(17):3194\u2013200.","journal-title":"J Clin Oncol."},{"issue":"20","key":"1456_CR19","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/jnci\/djq362","volume":"102","author":"P Hoskins","year":"2010","unstructured":"Hoskins P, et al. Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel. J Natl Cancer Inst. 2010;102(20):1547\u201356.","journal-title":"J Natl Cancer Inst."},{"issue":"5","key":"1456_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409\u201336.","journal-title":"CA Cancer J Clin."},{"issue":"5233","key":"1456_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.270.5233.50","volume":"270","author":"CT Keith","year":"1995","unstructured":"Keith CT, Schreiber SL. PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science. 1995;270(5233):50\u20131.","journal-title":"Science."},{"issue":"4","key":"1456_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020;21(4):183\u2013203.","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"5","key":"1456_CR23","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.molcel.2018.04.024","volume":"70","author":"L He","year":"2018","unstructured":"He L, et al. mTORC1 promotes metabolic reprogramming by the suppression of GSK3-dependent Foxk1 phosphorylation. Mol Cell. 2018;70(5):949-960 e4.","journal-title":"Mol Cell."},{"issue":"12","key":"1456_CR24","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","volume":"18","author":"D Mossmann","year":"2018","unstructured":"Mossmann D, Park S, Hall MN. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer. 2018;18(12):744\u201357.","journal-title":"Nat Rev Cancer."},{"key":"1456_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.semcancer.2019.07.003","volume":"59","author":"AK Murugan","year":"2019","unstructured":"Murugan AK. mTOR: role in cancer, metastasis and drug resistance. Semin Cancer Biol. 2019;59:92\u2013111.","journal-title":"Semin Cancer Biol."},{"issue":"2","key":"1456_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","volume":"39","author":"K Duvel","year":"2010","unstructured":"Duvel K, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell. 2010;39(2):171\u201383.","journal-title":"Mol Cell."}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-024-01456-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-024-01456-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-024-01456-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T01:05:31Z","timestamp":1719882331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-024-01456-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1456"],"URL":"https:\/\/doi.org\/10.1007\/s43032-024-01456-4","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]},"assertion":[{"value":"24 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Shanghai Jiao Tong University Institutional Animal Care and Use Committee (IACUC) (approval letter no. A2023080).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}